BHCM
REPL icon

Brevan Howard Capital Management’s Replimune Group REPL Stock Holding History

Brevan Howard Capital Management’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$275K Sell
35,893
-17,068
-32% -$130K ﹤0.01% 1681
2025
Q4 		$515K Hold
52,961
– – 0.01% 1101
2025
Q3 		$222K Sell
52,961
-5,281
-9% -$33.7K ﹤0.01% 1708
2025
Q2 		$541K Buy
+58,242
New +$508K ﹤0.01% 1327
2024
Q3 		– Sell
-39,170
Closed -$353K – 1382
2024
Q2 		$353K Buy
39,170
+20,999
+116% +$146K ﹤0.01% 724
2024
Q1 		$148K Buy
+18,171
New +$149K ﹤0.01% 849

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Brevan Howard Capital Management's REPL Position: Q1 2026 in Review

Brevan Howard Capital Management reduced its Replimune Group (REPL) stake by 32% in Q1 2026, selling an estimated $130K and leaving 35,893 shares worth $275K. The position accounts for ﹤0.01% of the portfolio, ranked #1681.

Brevan Howard Capital Management first reported a position in REPL in Q1 2024 and has held it in 6 quarters since. The position peaked at $541K in Q2 2025. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Brevan Howard Capital Management held 35,893 shares of Replimune Group worth $275K as of Q1 2026.
  • Brevan Howard Capital Management sold 17,068 Replimune Group shares in Q1 2026, an estimated $130K.
  • Replimune Group made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1681 holding.
  • Brevan Howard Capital Management first reported a position in Replimune Group in Q1 2024 and has held it in 6 quarters since.
  • Brevan Howard Capital Management's Replimune Group position peaked at $541K in Q2 2025.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.